BiliaryTractCancer near Newton, NJ

Biography: Myron M. Studner Professor of Cancer Research and Professor of Medicine and Epidemiology at Columbia University, Associate Director for Population Science, Leader of the Prevention, Control, and Disparities Program for the Herbert Irving Comprehensive Cancer Center at Columbia, and Co-Director of the Cancer Prevention Center of New York Presbyterian Hospital Dr. Neugut is a medical oncologist with a particular interest in gastroIntestinal tract cancers, especially of colorectal and gasteric cancers. Under the auspices of Columbia's MD/PhD program, he received his MD and a PhD in Pathobiology in 1977. He did his training in Internal Medicine at the Albert Einstein College of Medicine and fellowship in Medical Oncology at Memorial Sloan-Kettering Cancer Center. He returned to Columbia University as an Andrew Mellon Fellow in Epidemiology and Medicine to obtain an MPH in Epidemiology in 1983. Dr. Neugut then joined the faculty at Columbia University with appointments in Medicine and Epidemiology. As both a practicing medical oncologist and cancer epidemiologist, Dr. Alfred Neugut's major interests have been on GI tract cancers, notably the epidemiology of colorectal adenomas and cancer, as well as colonoscopic screening. He serves as co-principal investigator of the Long Island Breast Cancer Study Project, a large multi-center effort to explore environmental causes of breast cancer on Long Island. Most recently, his efforts have focused on more clinical topics, such as the epidemiology of second malignancies and the use of chemotherapy and radiation therapy among elderly cancer patients. Dr. Neugut focuses a great deal on racial disparities in incidence and survival from cancer and, in particular, variations across subgroups of people of African descent. He leads two large training grants in cancer-related population sciences that together fund 15 pre and postdoctoral trainees in cancer epidemiology, biostatistics, and environmental health sciences, and serves as a mentor to a number of junior faculty.

Care Philosophy: Throughout my career my professional and academic successes have been built on a foundation of values that we all share in caring for our patients; compassion, communication, respect, teamwork, and a commitment to providing patients exceptional, thoughtful and timely surgical care in the context of a multidisciplinary treatment plan. Accepted Health Plan information is only as accurate as the most current information submitted. Prior to your appointment, it is advisable to verify with a physician office that they are still a participating provider.

Biography: Dr. Catherine Shu isthe Price Family Associate Professor of Medicine anda board-certified medical oncologist specializing in the treatment of thoracic cancers, with a focus on lung cancer. She received her undergraduate degree from Princeton University, followed by her M.D. from Columbia University College of Physicians and Surgeons. After residency at Columbia University Medical Center, Dr. Shu completed her fellowship at Memorial Sloan Kettering Cancer Center, where she was appointed Chief Fellow. She currently serves as the Director of the Thoracic Medical Oncology Service. She has presented her work at numerous international conferences and has published in the top peer-reviewed oncology journals. She treats the entire spectrum of lung cancer, but has a particular interest in earlier stage and surgically resectable disease, specifically on drug combinations to help improve survival in this setting. Additionally, she devotes part of her research effort to patients with targetable mutations, helping to determine the best sequence of treatments. Of all her achievements, she is proudest to be able to offer individualized and compassionate care to each and every one of her patients. She understands that each patient and family carries forth a different set of beliefs, goals, and needs. Working alongside an exceptional multidisciplinary team, she is dedicated to improving the survival and bettering the quality of life of her patients.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience We are devoted to providing services that are patient centered and compassionate and care for you as a person nbsp;

Care Philosophy: Accepted Health Plan information is only as accurate as the most current information submitted. Prior to your appointment, it is advisable to verify with a physician office that they are still a participating provider.

Biography: Jennifer Ann Wagmiller, MD, MS, board-certified medical oncologist, joined The Cancer Center at Cooperman Barnabas Medical Center in 2007. She received her medical degree from the University of Medicine & Dentistry of New Jersey before completing her residency in Internal Medicine at Columbia Presbyterian Hospital in New York. Dr. Wagmiller completed a fellowship at the University of Rochester in Hematology/Oncology. Interested in clinical research, Dr. Wagmiller has been the author of numerous articles which have appeared in the American Journal of Hemotology/Oncology and the Journal of Oncology Practice. She enjoys teaching students and frequently lectures on cancer research for patients and lay audiences. She also has advanced training in health services research and cancer genetics. Dr. Wagmiller is a member of the American Society for Clinical Oncology.